Scilex Holding Co Share Price: SCLX (Scilex Holding Co) Stock Price Today & Updates | INDmoney

Question 1

What is Scilex Holding Co share price today?

Accepted Answer

Scilex Holding Co (SCLX) share price today is {{live_price}}.

Question 2

Can Indians buy Scilex Holding Co shares?

Accepted Answer

Yes, Indians can invest in the Scilex Holding Co (SCLX) from India.

With INDmoney, you can buy Scilex Holding Co at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Scilex Holding Co at zero transaction cost.

Question 3

How can I buy Scilex Holding Co shares from India?

Accepted Answer

It is very easy to buy Scilex Holding Co from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Scilex Holding Co be purchased?

Accepted Answer

Yes, you can buy fractional shares of Scilex Holding Co with INDmoney app.

Question 5

What are the documents required to start investing in Scilex Holding Co stocks?

Accepted Answer

To start investing in Scilex Holding Co, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Scilex Holding Co

Accepted Answer

Today’s highest price of Scilex Holding Co (SCLX) is {{1_rba_end}}.

Today’s lowest price of Scilex Holding Co (SCLX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Scilex Holding Co

Accepted Answer

Today's market capitalisation of Scilex Holding Co SCLX is 75.6M

Question 8

What is the 52 Week High and Low Range of Scilex Holding Co

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Scilex Holding Co is down from its 52 Week High?

Accepted Answer

Scilex Holding Co (SCLX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Scilex Holding Co is up from its 52 Week low?

Accepted Answer

Scilex Holding Co (SCLX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Scilex Holding Co?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Scilex Holding Co

Accepted Answer

Dr. Henry H. Ji Ph.D. is the current Chief Executive Officer (CEO) of Scilex Holding Co.

Period	Scilex Holding Co	Index (Russel 2000)
3 Months	-54.8%	0.0%
6 Months	-52.04%	0.0%
1 Year	-45.4%	0.0%
3 Years	-94.1%	-24.1%

Market Capitalization	75.6M
Book Value	-$1.77
Earnings Per Share (EPS)	-1.44
Wall Street Target Price	7.625

Profit Margin	-233.88%
Operating Margin TTM	-95.44%

Return On Assets TTM	-53.64%
Return On Equity TTM	0.0%

Revenue TTM	50.8M
Revenue Per Share TTM	0.44
Quarterly Revenue Growth YOY	30.099999999999998%
Gross Profit TTM	27.2M
EBITDA	-95.0M
Diluted Eps TTM	-1.44
Quarterly Earnings Growth YOY	0.0

Scilex Holding Co (SCLX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Decreasing Net Profit

Vs LLY

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.5
EPS Estimate Next Year	-0.4
EPS Estimate Current Quarter	-0.21
EPS Estimate Next Quarter	-0.19

	FY20	Y/Y Change
Revenue	23.6M	↑ 12.01%
Net Income	-47.5M	↓ 73.39%
Net Profit Margin	-201.69%	↑ 647.42%

	FY21	Y/Y Change
Revenue	31.3M	↑ 32.92%
Net Income	-88.4M	↑ 86.08%
Net Profit Margin	-282.35%	↓ 80.66%

	FY22	Y/Y Change
Revenue	38.0M	↑ 21.45%
Net Income	-23.4M	↓ 73.58%
Net Profit Margin	-61.43%	↑ 220.92%

	FY23	Y/Y Change
Revenue	46.7M	↑ 22.9%
Net Income	-114.3M	↑ 389.35%
Net Profit Margin	-244.59%	↓ 183.16%

	Q1 FY23	Q/Q Change
Revenue	10.6M	↓ 11.22%
Net Income	-30.8M	↑ 71.96%
Net Profit Margin	-290.62%	↓ 140.57%

	Q2 FY23	Q/Q Change
Revenue	12.6M	↑ 18.9%
Net Income	-26.6M	↓ 13.35%
Net Profit Margin	-211.8%	↑ 78.82%

	Q3 FY23	Q/Q Change
Revenue	10.1M	↓ 19.59%
Net Income	-35.5M	↑ 33.32%
Net Profit Margin	-351.18%	↓ 139.38%

	Q4 FY23	Q/Q Change
Revenue	13.5M	↑ 33.06%
Net Income	-21.4M	↓ 39.77%
Net Profit Margin	-158.97%	↑ 192.21%

	Q1 FY24	Q/Q Change
Revenue	10.9M	↓ 19.15%
Net Income	-24.4M	↑ 13.91%
Net Profit Margin	-223.97%	↓ 65.0%

	FY20	Y/Y Change
Total Assets	81.5M	-
Total Liabilities	223.2M	-

	FY21	Y/Y Change
Total Assets	77.9M	↓ 4.38%
Total Liabilities	301.8M	↑ 35.23%

	FY22	Y/Y Change
Total Assets	86.5M	↑ 11.03%
Total Liabilities	50.3M	↓ 83.34%

	FY23	Y/Y Change
Total Assets	101.3M	↑ 17.08%
Total Liabilities	274.2M	↑ 445.35%

	Q2 FY24	Q/Q Change
Revenue	16.4M	↑ 50.4%
Net Income	-37.6M	↑ 54.17%
Net Profit Margin	-229.58%	↓ 5.61%

	Q2 FY23	Q/Q Change
Total Assets	126.5M	↑ 46.96%
Total Liabilities	116.0M	↑ 54.78%

	Q3 FY23	Q/Q Change
Total Assets	80.5M	↓ 36.32%
Total Liabilities	243.2M	↑ 109.57%

	Q4 FY23	Q/Q Change
Total Assets	101.3M	↑ 25.81%
Total Liabilities	274.2M	↑ 12.77%

	Q2 FY24	Q/Q Change
Total Assets	104.5M	↑ 14.58%
Total Liabilities	319.2M	↑ 13.6%

	FY19	Y/Y Change
Operating Cash Flow	-60.4M	-
Investing Cash Flow	-17.6M	-
Financing Cash Flow	15.8M	-

	FY20	Y/Y Change
Operating Cash Flow	-31.5M	↓ 47.93%
Investing Cash Flow	-25.0K	↓ 99.86%
Financing Cash Flow	-19.2M	↓ 221.51%

	FY21	Y/Y Change
Operating Cash Flow	-28.7M	↓ 8.89%
Investing Cash Flow	-139.4M	↑ 557420.0%
Financing Cash Flow	28.2M	↓ 246.91%

	FY22	Y/Y Change
Operating Cash Flow	-21.3M	↓ 25.84%
Investing Cash Flow	-2.1M	↓ 98.52%
Financing Cash Flow	21.2M	↓ 24.83%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-7.7M	↑ 968.14%
Investing Cash Flow	-8.0K	↓ 99.98%
Financing Cash Flow	10.6M	↑ 2395.07%

	Q2 FY23	Q/Q Change
Operating Cash Flow	-13.5M	↑ 73.98%
Investing Cash Flow	-8.0K	↑ 0.0%
Financing Cash Flow	43.5M	↑ 309.62%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Scilex Holding Co	-43.17%	-52.04%	-45.4%	-94.1%	-94.1%
Eli Lilly And Company	-17.51%	-6.6%	26.02%	187.94%	545.37%
Johnson & Johnson	-4.86%	1.3%	3.1%	-2.63%	12.62%
Merck & Co. Inc.	-6.36%	-23.83%	-1.79%	22.32%	16.86%
Novo Nordisk A/s	-11.88%	-23.43%	-0.61%	84.54%	276.9%
Abbvie Inc	-9.02%	7.59%	24.02%	48.49%	99.57%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Scilex Holding Co	NA	NA	NA	-0.5	0.0	-0.54	NA	-1.77
Eli Lilly And Company	78.73	78.73	0.69	13.16	0.65	0.14	0.01	15.83
Johnson & Johnson	25.45	25.45	0.92	9.96	0.21	0.08	0.03	29.14
Merck & Co. Inc.	20.22	20.22	0.07	7.74	0.28	0.11	0.03	17.58
Novo Nordisk A/s	34.03	34.03	1.57	22.7	0.89	0.21	0.01	27.07
Abbvie Inc	58.45	58.45	0.4	10.94	0.56	0.08	0.04	3.41

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Scilex Holding Co	Buy	$75.6M	-94.1%	NA	-233.88%
Eli Lilly And Company	Buy	$715.2B	545.37%	78.73	20.48%
Johnson & Johnson	Buy	$370.8B	12.62%	25.45	16.74%
Merck & Co. Inc.	Buy	$246.5B	16.86%	20.22	19.23%
Novo Nordisk A/s	Buy	$472.8B	276.9%	34.03	35.01%
Abbvie Inc	Buy	$296.5B	99.57%	58.45	9.22%

Organization	Scilex Holding Co
Employees	113
CEO	Dr. Henry H. Ji Ph.D.
Industry	Healthcare